Skip to main content
Equibles
MSPR logo

MSPR · MSP Recovery, Inc.

Track MSPR — free

Use MSPR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.07 -0.13 (-63.97%) At close · Dec 22
Rebalance outlook locked
Going-concern doubt — flagged Nov 19, 2025

Substantial doubt about the company's ability to continue as a going concern.

“The Company has concluded that there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern. Management is taking steps to raise additional funds to address its operating and financial cash requirements to continue operations. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations. The financial statements contain no adjustments for the outcome of this uncertainty.”
View the 10-Q filed Nov 19, 2025
Market Cap
$1,424
Shares
14.25M

MSPR metrics

34 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.07
Market cap
$1,424

Price action

19 metrics
Price change (1W)
-71.4%
Price change (30D)
—
Price change (3M)
-94.9%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
371.3%
Beta
—
RSI (14D)
25.7
Price vs SMA 50
-85.6%
Price vs SMA 200
—
Avg volume (3M)
28.22M
Relative volume
0.1
Average dollar volume
$14.89M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
14.25M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
-1,253,514.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-50,489,977.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-03-31

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$1.25B
Net income (TTM)
−$719.22M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+180.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-46.3%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$17.86M
Quick ratio
0.0
Interest coverage
-2.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.82M
Latest balance sheet
Cash & equivalents
$1.82M
Total assets
$1.55B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.33M
Capital expenditures (TTM)
$527,000
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$1.88M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1
13F filer change QoQ
-1
Institutional ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1802450 CUSIP 553745407 Visit website